下肢静脈瘤治療機器市場：デバイス、治療タイプ、エンドユーザー別-2025-2030年の世界予測

下肢静脈瘤治療機器市場は、2023年に15億2,000万米ドルと評価され、2024年には16億9,000万米ドルに達すると予測され、CAGR 11.74％で成長し、2030年には33億1,000万米ドルに達すると予測されています。

下肢静脈瘤治療機器市場の範囲と定義は、痛みや不快感の原因となる静脈の拡大とねじれを特徴とする一般的な症状である静脈瘤を治療するために設計された医療ツールの広い配列を包含します。静脈内レーザー療法、高周波焼灼療法、注射硬化療法などの治療オプションは、症状を緩和し、患者の生活の質を向上させるために医療現場で適用されています。これらの機器の必要性は、人口の高齢化、座りっぱなしのライフスタイル、肥満率の増加などの要因による静脈瘤の高い有病率から生じています。これらの機器は主に病院、診療所、外来手術センターで使用され、血管外科医、インターベンショナル・ラジオロジスト、皮膚科医などのエンドユーザーを対象としています。

この市場に影響を与える主な成長要因には、技術の進歩、低侵襲手術に対する患者の嗜好の高まり、ヘルスケア支出の増加などがあります。認知度の向上と早期診断への取り組みも市場力学を後押ししています。超音波ガイド下装置やポータブル治療システムなどの最近の技術革新は、市場拡大の新たな機会を提供しています。市場関係者への提言としては、アンメット・メディカル・ニーズのある新興市場への注力、技術進歩のための戦略的パートナーシップの促進、需要拡大のための患者教育への投資などが挙げられます。

しかし、市場は厳しい規制、治療に伴う副作用や合併症の可能性、高額な治療費などの課題に直面しており、普及の妨げになる可能性があります。さらに、償還の問題も引き続き制約となっています。こうした課題を克服するためには、治療機器の安全性と有効性の向上、スケーラブルな生産技術によるコスト削減、有利な償還政策の確保に重点を置いた技術革新が必要です。

最良の研究開発分野としては、患者の予後を改善する次世代機器の開発、治療計画における予測分析のための人工知能の統合、体内に安全に吸収される生分解性材料の探求などが挙げられます。市場の性質は競合が激しく、急速に進化しているため、研究主導型企業が提供製品の継続的改善と差別化を通じて主導権を握る余地は大きいです。

市場力学：急速に進化する下肢静脈瘤治療機器市場の主要市場インサイトの解明

下肢静脈瘤治療機器市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 静脈瘤の発生率の増加
  • 低侵襲治療への嗜好の高まり
• 市場抑制要因
  • 治療に伴う高コスト
• 市場機会
  • 下肢静脈瘤治療機器における技術の進歩
  • 新規下肢静脈瘤治療機器開発のための多額の投資
• 市場の課題
  • 下肢静脈瘤治療機器に関連するリスク

ポーターのファイブフォース：下肢静脈瘤治療機器市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、下肢静脈瘤治療機器市場の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：下肢静脈瘤治療機器市場における外部からの影響の把握

外部マクロ環境要因は、下肢静脈瘤治療機器市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析下肢静脈瘤治療機器市場における競合情勢の把握

下肢静脈瘤治療機器市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス下肢静脈瘤治療機器市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、下肢静脈瘤治療機器市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨下肢静脈瘤治療機器市場における成功への道筋を描く

下肢静脈瘤治療機器市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 静脈瘤の発症率の増加
    • 低侵襲治療手順の好感度が上昇
  • 抑制要因
    • 治療にかかる費用が高い
  • 機会
    • 下肢静脈瘤治療機器における技術的進歩
    • 新規開発のための多額の投資下肢静脈瘤治療機器
  • 課題
    • 下肢静脈瘤治療機器に関連するリスク
• 市場セグメンテーション分析
  • デバイス：非常に複雑な状況での外科用製品の好感度が高まっている
  • 治療の種類：重度の静脈瘤に対する外科的結紮術とストリッピング術の使用が急増
  • エンドユーザー：皮膚外科センターにおける下肢静脈瘤治療機器の応用の進化
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 下肢静脈瘤治療機器市場：デバイス別

• アブレーション装置
• 外科用製品
• 静脈閉鎖システム

第7章 下肢静脈瘤治療機器市場治療の種類別

• 静脈内アブレーション
• 硬化療法
• 外科的結紮とストリッピング

第8章 下肢静脈瘤治療機器市場：エンドユーザー別

• 外来診療ユニット
• 皮膚外科センター
• 病院・クリニック

第9章 南北アメリカの下肢静脈瘤治療機器市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の下肢静脈瘤治療機器市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの下肢静脈瘤治療機器市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • セラクリオン、FDA承認のピボタル研究の一環としてソノベインで治療した最初の患者を発表
  • バイオリテックのエルフラジアル2リングプロとレオナルドレーザー1940が静脈治療用に導入されました
  • セラクリオン、静脈瘤研究でFDA IDE承認を取得
• 戦略分析と提言

企業一覧

• AccuVein, Inc.
• Alma Lasers Ltd.
• Angiodynamics Inc
• biolitec AG
• Candela Corporation
• Chemische Fabrik Kreussler & Co. GmbH
• Chuback Medical Group
• F Care Systems
• Fotona d.o.o.
• GIGAALASER Group
• Intact Vascular, Inc.
• Intense Medical & Dental System Limited
• InVera Medical
• Lumenis Be Ltd. by Boston Scientific Corporation
• Medico's Hirata Inc.
• Medtronic PLC
• Merit Medical Systems
• Olympus Corporation
• Quanta System S.p.A.
• Sciton Inc.
• Teleflex Incorporated
• THERACLION S. A.
• VVT Medical
• WON TECH Co., Ltd.

LIST OF FIGURES

• FIGURE 1. VARICOSE VEIN TREATMENT DEVICES MARKET RESEARCH PROCESS
• FIGURE 2. VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY DEVICE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY DEVICE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY END-USERS, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY END-USERS, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. VARICOSE VEIN TREATMENT DEVICES MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. VARICOSE VEIN TREATMENT DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. VARICOSE VEIN TREATMENT DEVICES MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. VARICOSE VEIN TREATMENT DEVICES MARKET DYNAMICS
• TABLE 7. GLOBAL VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY ABLATION DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY SURGICAL PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY VENOUS CLOSURE SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY ENDOVENOUS ABLATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY SCLEROTHERAPY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY SURGICAL LIGATION & STRIPPING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY AMBULATORY CARE UNIT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY DERMATOSURGERY CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. AMERICAS VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 20. AMERICAS VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 22. AMERICAS VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 23. ARGENTINA VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 24. ARGENTINA VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 25. ARGENTINA VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 26. BRAZIL VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 27. BRAZIL VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 28. BRAZIL VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 29. CANADA VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 30. CANADA VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 31. CANADA VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 32. MEXICO VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 33. MEXICO VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 34. MEXICO VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 35. UNITED STATES VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 36. UNITED STATES VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 37. UNITED STATES VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 38. UNITED STATES VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 39. ASIA-PACIFIC VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 40. ASIA-PACIFIC VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 41. ASIA-PACIFIC VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 42. ASIA-PACIFIC VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 43. AUSTRALIA VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 44. AUSTRALIA VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 45. AUSTRALIA VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 46. CHINA VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 47. CHINA VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 48. CHINA VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 49. INDIA VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 50. INDIA VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 51. INDIA VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 52. INDONESIA VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 53. INDONESIA VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 54. INDONESIA VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 55. JAPAN VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 56. JAPAN VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 57. JAPAN VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 58. MALAYSIA VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 59. MALAYSIA VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 60. MALAYSIA VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 61. PHILIPPINES VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 62. PHILIPPINES VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 63. PHILIPPINES VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 64. SINGAPORE VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 65. SINGAPORE VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 66. SINGAPORE VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 67. SOUTH KOREA VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 68. SOUTH KOREA VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 69. SOUTH KOREA VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 70. TAIWAN VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 71. TAIWAN VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 72. TAIWAN VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 73. THAILAND VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 74. THAILAND VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 75. THAILAND VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 76. VIETNAM VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 77. VIETNAM VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 78. VIETNAM VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 79. EUROPE, MIDDLE EAST & AFRICA VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 80. EUROPE, MIDDLE EAST & AFRICA VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 81. EUROPE, MIDDLE EAST & AFRICA VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 82. EUROPE, MIDDLE EAST & AFRICA VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 83. DENMARK VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 84. DENMARK VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 85. DENMARK VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 86. EGYPT VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 87. EGYPT VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 88. EGYPT VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 89. FINLAND VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 90. FINLAND VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 91. FINLAND VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 92. FRANCE VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 93. FRANCE VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 94. FRANCE VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 95. GERMANY VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 96. GERMANY VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 97. GERMANY VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 98. ISRAEL VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 99. ISRAEL VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 100. ISRAEL VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 101. ITALY VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 102. ITALY VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 103. ITALY VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 104. NETHERLANDS VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 105. NETHERLANDS VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 106. NETHERLANDS VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 107. NIGERIA VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 108. NIGERIA VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 109. NIGERIA VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 110. NORWAY VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 111. NORWAY VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 112. NORWAY VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 113. POLAND VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 114. POLAND VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 115. POLAND VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 116. QATAR VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 117. QATAR VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 118. QATAR VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 119. RUSSIA VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 120. RUSSIA VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 121. RUSSIA VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 122. SAUDI ARABIA VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 123. SAUDI ARABIA VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 124. SAUDI ARABIA VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 125. SOUTH AFRICA VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 126. SOUTH AFRICA VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 127. SOUTH AFRICA VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 128. SPAIN VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 129. SPAIN VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 130. SPAIN VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 131. SWEDEN VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 132. SWEDEN VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 133. SWEDEN VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 134. SWITZERLAND VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 135. SWITZERLAND VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 136. SWITZERLAND VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 137. TURKEY VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 138. TURKEY VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 139. TURKEY VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 140. UNITED ARAB EMIRATES VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 141. UNITED ARAB EMIRATES VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 142. UNITED ARAB EMIRATES VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 143. UNITED KINGDOM VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY DEVICE, 2018-2030 (USD MILLION)
• TABLE 144. UNITED KINGDOM VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 145. UNITED KINGDOM VARICOSE VEIN TREATMENT DEVICES MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
• TABLE 146. VARICOSE VEIN TREATMENT DEVICES MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 147. VARICOSE VEIN TREATMENT DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

The Varicose Vein Treatment Devices Market was valued at USD 1.52 billion in 2023, expected to reach USD 1.69 billion in 2024, and is projected to grow at a CAGR of 11.74%, to USD 3.31 billion by 2030.

The scope and definition of the varicose vein treatment devices market encompass a wide array of medical tools designed to treat varicose veins, a common condition characterized by enlarged and twisted veins that cause pain and discomfort. Treatment options such as endovenous laser therapy, radiofrequency ablation, and injection sclerotherapy are applied in medical settings to alleviate symptoms and improve patient quality of life. The necessity of these devices stems from the high prevalence of varicose veins, driven by factors like aging populations, sedentary lifestyles, and increased obesity rates. These devices find application predominantly in hospitals, clinics, and outpatient surgical centers, targeting end-users like vascular surgeons, interventional radiologists, and dermatologists.

Key growth factors influencing this market include technological advancements, increasing patient preference for minimally invasive procedures, and rising healthcare expenditures. The growing awareness and early diagnosis efforts also boost market dynamics. Recent innovations, such as ultrasound-guided devices and portable treatment systems, offer new opportunities for market expansion. Recommendations for market players include focusing on emerging markets with unmet medical needs, fostering strategic partnerships for technological advancements, and investing in patient education to boost demand.

However, the market faces challenges such as stringent regulations, potential side effects or complications associated with treatments, and high procedural costs, which may hinder widespread adoption. Additionally, reimbursement issues continue to pose limitations. To overcome these challenges, innovation should focus on enhancing the safety and efficacy of treatment devices, reducing costs through scalable production techniques, and securing favorable reimbursement policies.

Best areas for research include developing next-generation devices with improved patient outcomes, integrating artificial intelligence for predictive analysis in treatment planning, and exploring biodegradable materials that can be safely absorbed by the body. The nature of the market is competitive and rapidly evolving, with significant scope for research-driven companies to lead through continuous improvement and differentiation of their product offerings.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Varicose Vein Treatment Devices Market

The Varicose Vein Treatment Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increase in the incidence of varicose vein conditions
  • Rise in the preference for minimally invasive treatment procedures
• Market Restraints
  • High cost associated with the treatment
• Market Opportunities
  • Technological advancements in varicose vein treatment devices
  • Significant investments for development of novel varicose vein treatment devices
• Market Challenges
  • Risks associated with varicose vein treatment devices

Porter's Five Forces: A Strategic Tool for Navigating the Varicose Vein Treatment Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Varicose Vein Treatment Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Varicose Vein Treatment Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Varicose Vein Treatment Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Varicose Vein Treatment Devices Market

A detailed market share analysis in the Varicose Vein Treatment Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Varicose Vein Treatment Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Varicose Vein Treatment Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Varicose Vein Treatment Devices Market

A strategic analysis of the Varicose Vein Treatment Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Varicose Vein Treatment Devices Market, highlighting leading vendors and their innovative profiles. These include AccuVein, Inc., Alma Lasers Ltd., Angiodynamics Inc, biolitec AG, Candela Corporation, Chemische Fabrik Kreussler & Co. GmbH, Chuback Medical Group, F Care Systems, Fotona d.o.o., GIGAALASER Group, Intact Vascular, Inc., Intense Medical & Dental System Limited, InVera Medical, Lumenis Be Ltd. by Boston Scientific Corporation, Medico's Hirata Inc., Medtronic PLC, Merit Medical Systems, Olympus Corporation, Quanta System S.p.A., Sciton Inc., Teleflex Incorporated, THERACLION S. A., VVT Medical, and WON TECH Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Varicose Vein Treatment Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Device, market is studied across Ablation Devices, Surgical Products, and Venous Closure Systems.
• Based on Treatment Type, market is studied across Endovenous Ablation, Sclerotherapy, and Surgical Ligation & Stripping.
• Based on End-Users, market is studied across Ambulatory Care Unit, Dermatosurgery Centers, and Hospitals & Clinics.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increase in the incidence of varicose vein conditions
    • 5.1.1.2. Rise in the preference for minimally invasive treatment procedures
  • 5.1.2. Restraints
    • 5.1.2.1. High cost associated with the treatment
  • 5.1.3. Opportunities
    • 5.1.3.1. Technological advancements in varicose vein treatment devices
    • 5.1.3.2. Significant investments for development of novel varicose vein treatment devices
  • 5.1.4. Challenges
    • 5.1.4.1. Risks associated with varicose vein treatment devices
• 5.2. Market Segmentation Analysis
  • 5.2.1. Device: Increasing preference for surgical products in highly complex conditions
  • 5.2.2. Treatment Type: Burgeoning usage of surgical ligation & stripping for more severe varicose vein conditions
  • 5.2.3. End-Users: Evolving application of varicose vein treatment devices in dermatosurgery centers
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Varicose Vein Treatment Devices Market, by Device

• 6.1. Introduction
• 6.2. Ablation Devices
• 6.3. Surgical Products
• 6.4. Venous Closure Systems

7. Varicose Vein Treatment Devices Market, by Treatment Type

• 7.1. Introduction
• 7.2. Endovenous Ablation
• 7.3. Sclerotherapy
• 7.4. Surgical Ligation & Stripping

8. Varicose Vein Treatment Devices Market, by End-Users

• 8.1. Introduction
• 8.2. Ambulatory Care Unit
• 8.3. Dermatosurgery Centers
• 8.4. Hospitals & Clinics

9. Americas Varicose Vein Treatment Devices Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Varicose Vein Treatment Devices Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Varicose Vein Treatment Devices Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
  • 12.3.1. Theraclion Reveals First Patients Treated With SONOVEIN as Part of the FDA-approved Pivotal Study
  • 12.3.2. Biolitec's Elves Radial 2ring Pro and Leonardo Laser 1940 Introduced for Venous Treatment
  • 12.3.3. Theraclion Wins FDA IDE Approval For Varicose Veins Study
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. AccuVein, Inc.
• 2. Alma Lasers Ltd.
• 3. Angiodynamics Inc
• 4. biolitec AG
• 5. Candela Corporation
• 6. Chemische Fabrik Kreussler & Co. GmbH
• 7. Chuback Medical Group
• 8. F Care Systems
• 9. Fotona d.o.o.
• 10. GIGAALASER Group
• 11. Intact Vascular, Inc.
• 12. Intense Medical & Dental System Limited
• 13. InVera Medical
• 14. Lumenis Be Ltd. by Boston Scientific Corporation
• 15. Medico's Hirata Inc.
• 16. Medtronic PLC
• 17. Merit Medical Systems
• 18. Olympus Corporation
• 19. Quanta System S.p.A.
• 20. Sciton Inc.
• 21. Teleflex Incorporated
• 22. THERACLION S. A.
• 23. VVT Medical
• 24. WON TECH Co., Ltd.